Lab
Laboratorio Clinico Y Bacteriologico Genesis INC.
Laboratorio Clinico Y Bacteriologico Genesis INC. was paid $7.51M by Medicaid between Jan 2018 and Dec 2024, across 144 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 11% of everything it billed.
33Billing provider infoLABORATORIO CLINICO Y BACTERIOLOGICO GENESIS INC.
PATILLAS, PR 00723
PATILLAS, PR 00723
33aNPI1568405793assigned 06/14/2006
33bProvider typeClinical Medical Laboratory
28Total paid$7.51M
24GClaims641,611
24DCodes billed144
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#10 of 777
Median peer was paid$278K
This provider vs. median27×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 57,020 | $491K | |
| 2019 | 59,221 | $503K | |
| 2020 | 55,915 | $613K | |
| 2021 | 101,458 | $1.54M | |
| 2022 | 102,739 | $1.40M | |
| 2023 | 142,468 | $1.54M | |
| 2024incomplete | 122,790 | $1.42M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 11% | 51,110 | 46,376 | $795K |
| 80061 | Lipid panel | 8.3% | 50,130 | 45,488 | $625K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 8.2% | 17,279 | 15,026 | $615K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 8.0% | 25,453 | 21,451 | $600K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6.8% | 10,078 | 8,699 | $510K |
| 80053 | Comprehensive metabolic panel | 5.8% | 44,377 | 39,737 | $433K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.0% | 54,296 | 48,123 | $375K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.5% | 12,680 | 11,127 | $339K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.0% | 25,180 | 22,711 | $224K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.5% | 13,079 | 6,407 | $187K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.0% | 19,742 | 18,069 | $150K |
| 86702 | 2.0% | 12,767 | 11,187 | $148K |
132 more codes
| 81000 | 1.9% | 45,293 | $146K | |
| 85027 | 1.8% | 23,770 | $132K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.6% | 3,770 | $119K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.6% | 3,720 | $118K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.5% | 2,250 | $113K |
| 86701 | 1.5% | 13,665 | $111K | |
| 82274 | 1.5% | 7,733 | $110K | |
| 80074 | 1.5% | 2,534 | $109K | |
| 86328 | 1.4% | 5,684 | $106K | |
| 84439 | 1.2% | 11,291 | $92K | |
| 84153 | 1.2% | 5,583 | $92K | |
| 86738 | 1.2% | 7,638 | $92K | |
| 82043 | 1.2% | 17,315 | $88K | |
| 87088 | <1% | 8,375 | $65K | |
| 82607 | <1% | 4,648 | $64K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,908 | $53K |
| 86803 | <1% | 3,450 | $45K | |
| 81001 | <1% | 15,111 | $44K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,721 | $41K |
| 84436 | <1% | 6,019 | $36K | |
| 82570 | <1% | 6,205 | $29K | |
| 85730 | <1% | 5,291 | $28K | |
| 86038 | <1% | 2,536 | $27K | |
| 86592 | <1% | 6,587 | $26K | |
| 82947 | <1% | 6,956 | $25K | |
| 84479 | <1% | 3,906 | $21K | |
| 84146 | <1% | 1,205 | $21K | |
| 84702 | <1% | 1,537 | $21K | |
| 80076 | <1% | 2,974 | $20K | |
| 85651 | <1% | 6,238 | $20K | |
| 82378 | <1% | 1,176 | $20K | |
| 82728 | <1% | 1,538 | $19K | |
| 82105 | <1% | 1,221 | $18K | |
| 85610 | <1% | 5,188 | $18K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 558 | $17K |
| 83001 | <1% | 978 | $17K | |
| 86140 | <1% | 3,387 | $15K | |
| 84550 | <1% | 3,897 | $15K | |
| 83655 | <1% | 1,574 | $15K | |
| 87340 | <1% | 1,631 | $15K | |
| 87400 | <1% | 721 | $14K | |
| 82677 | <1% | 653 | $14K | |
| 83970 | <1% | 376 | $14K | |
| 82746 | <1% | 1,006 | $14K | |
| 84703 | <1% | 2,012 | $13K | |
| 84403 | <1% | 552 | $13K | |
| 86762 | <1% | 996 | $13K | |
| 87177 | <1% | 1,117 | $12K | |
| 87581 | <1% | 364 | $11K | |
| 83540 | <1% | 1,707 | $10K | |
| 86336 | <1% | 671 | $9K | |
| 86304 | <1% | 471 | $9K | |
| 82950 | <1% | 1,977 | $8K | |
| 80069 | <1% | 1,019 | $8K | |
| 82785 | <1% | 517 | $8K | |
| 86003 | <1% | 181 | $8K | |
| 84460 | <1% | 1,581 | $7K | |
| 84450 | <1% | 1,565 | $7K | |
| 82951 | <1% | 622 | $7K | |
| 86696 | <1% | 288 | $6K | |
| 86430 | <1% | 1,127 | $6K | |
| 83002 | <1% | 322 | $6K | |
| 86886 | <1% | 1,105 | $5K | |
| 86160 | <1% | 417 | $5K | |
| 86225 | <1% | 356 | $4K | |
| 87899 | <1% | 363 | $4K | |
| 84481 | <1% | 266 | $4K | |
| 86901 | <1% | 1,479 | $4K | |
| 86900 | <1% | 1,482 | $4K | |
| 85660 | <1% | 799 | $4K | |
| 86161 | <1% | 363 | $4K | |
| 86800 | <1% | 262 | $4K | |
| 87071 | <1% | 447 | $4K | |
| 82565 | <1% | 795 | $4K | |
| 84156 | <1% | 1,035 | $3K | |
| 87580 | <1% | 178 | $3K | |
| 84154 | <1% | 193 | $3K | |
| 86200 | <1% | 272 | $3K | |
| 80050 | General health panel | <1% | 317 | $3K |
| 87490 | <1% | 154 | $3K | |
| 84100 | <1% | 1,003 | $3K | |
| 86695 | <1% | 189 | $3K | |
| 84480 | <1% | 200 | $3K | |
| 86300 | <1% | 109 | $3K | |
| 87590 | <1% | 131 | $3K | |
| 82270 | <1% | 861 | $2K | |
| 82248 | <1% | 547 | $2K | |
| 87536 | <1% | 25 | $2K | |
| 83615 | <1% | 354 | $2K | |
| 83550 | <1% | 231 | $2K | |
| 86769 | <1% | 54 | $2K | |
| 86376 | <1% | 111 | $1K | |
| 84520 | <1% | 396 | $1K | |
| 82652 | <1% | 40 | $1K | |
| 82977 | <1% | 224 | $1K | |
| 82670 | <1% | 46 | $1K | |
| 87077 | <1% | 159 | $1K | |
| 82672 | <1% | 47 | $914.47 | |
| 82952 | <1% | 219 | $828.34 | |
| 82784 | <1% | 43 | $794.82 | |
| 86706 | <1% | 85 | $787.28 | |
| 87186 | <1% | 121 | $708.97 | |
| 87081 | <1% | 110 | $693.69 | |
| 84402 | <1% | 27 | $651.70 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 36 | $566.86 |
| 86431 | <1% | 101 | $561.32 | |
| 86361 | <1% | 12 | $302.73 | |
| 82550 | <1% | 41 | $263.33 | |
| 82044 | <1% | 73 | $241.58 | |
| 82040 | <1% | 113 | $234.03 | |
| 82465 | <1% | 58 | $221.29 | |
| 83721 | <1% | 25 | $216.86 | |
| 84432 | <1% | 13 | $201.50 | |
| 82150 | <1% | 36 | $185.76 | |
| 86704 | <1% | 16 | $180.98 | |
| 80185 | <1% | 14 | $155.80 | |
| 83690 | <1% | 26 | $155.57 | |
| 87181 | <1% | 31 | $144.32 | |
| 84478 | <1% | 28 | $137.29 | |
| 86705 | <1% | 12 | $111.95 | |
| 86039 | <1% | 16 | $100.99 | |
| 87185 | <1% | 16 | $74.14 | |
| 83735 | <1% | 12 | $73.35 | |
| 84132 | <1% | 33 | $70.02 | |
| 83570 | <1% | 12 | $58.78 | |
| 85044 | <1% | 12 | $51.47 | |
| 82374 | <1% | 12 | $45.14 | |
| 84295 | <1% | 12 | $44.42 | |
| 85002 | <1% | 12 | $41.34 | |
| 82272 | <1% | 14 | $30.38 | |
| 85018 | <1% | 13 | $28.50 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 3,120 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCARRASQUILLO, LUIS (MANAGER)